Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8936730 | 0.89 | TP53 (0.53) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL8936648 | 0.77 | TP53 (0.45) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL8936654 | 0.77 | TP53 (0.45) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL9853427 | 0.77 | TP53 (0.48) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL9853429 | 0.75 | NR1H2 (0.47) | TP53KMT2AMAPTPOLBLMNA | |
| SCHEMBL9369052 | 0.75 | BRD4 (0.45) | TP53KMT2AMAPTTHRBMEN1 | |
| SCHEMBL9684779 | 0.75 | ALDH1A1 (0.52) | — | |
| SCHEMBL9101435 | 0.72 | TP53 (0.60) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL9101209 | 0.72 | TP53 (0.54) | TP53KMT2AMAPTTHRBPOLB | |
| SCHEMBL8936669 | 0.71 | TP53 (0.46) | TP53KMT2AMAPTTHRBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5547951-A | ENZYME INHIBITORS; AIDS | BOEHRINGER INGELHEIM PHARAMCEUTICALS, INC. (US) | 1996-08-20 | — | — | US | disclosed |
| EP-0417534-A1 | Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS | Boehringer Ingelheim Pharmaceuticals Inc. (US) | 1991-03-20 | — | — | EP | disclosed |